Thyroid Tablets USP
14 stories tracked · latest
News coverage of the Thyroid Tablets USP class action lawsuit, aggregated automatically from public reporting. Each item below is our own summary with a link to the original source — we never reproduce the source article's text.
Recent coverage
Thyroid medication recall classified under FDA most urgent level
Thyroid tablets are subject to a nationwide recall that the FDA has classified at its most urgent level.
Walmart announces recall of popular medication for health risk - SILive.com
Walmart announced a recall of a popular medication because of a health risk.
Thyroid Tablets Recalled Nationwide Due To Potential Over-Potency Risk - dermatologyadvisor.com
Thyroid tablets have been recalled nationwide because they may be more potent than intended.
Thyroid Tablets Recalled Nationwide Due To Potential Over - Potency Risk
Thyroid tablets have been recalled nationwide because they may contain overly potent doses.
Recalled Thyriod Medication Due To Being Superpotent
Vitruvias Therapeutics voluntarily recalled Thyroid Tablets USP 30 mg nationwide after FDA testing found the medication contained more active drug than its labeled strength.
Thyroid tablets recalled nationwide due to potential over-potency risk - Medical Xpress
Thyroid tablets have been recalled nationwide because they may be more potent than intended.
Thyroid medicine recalled. See affected product - USA Today
A thyroid medication has been recalled, with the report identifying affected products.
Thyroid medication recalled because it could be 'superpotent' - KCRA
A thyroid medication has been recalled because it may be excessively potent.
Vitruvias vanishes amid thyroid tablets recall over potential ‘superpotency’ concerns - BioSpace
Vitruvias has disappeared amid a recall of thyroid tablets due to potential excessive potency concerns.
Vitruvias Therapeutics recalls 30 mg thyroid tablets over superpotency - qz.com
Vitruvias Therapeutics has recalled its 30 mg thyroid tablets because they may be excessively potent.
Thyroid medication recalled nationwide after tablets found to be 'superpotent': FDA - Fox Business
The FDA announced a nationwide recall of thyroid medication after testing found some tablets to be excessively potent.
Thyroid medication recalled nationwide over potential superpotency risk
Vitruvias Therapeutics has recalled one nationwide lot of 30 mg Thyroid Tablets USP after testing indicated the medication may be overly potent.
Superpotent Thyroid Tablets Prompt Nationwide Recall - Medical Professionals Reference
A nationwide recall has been issued for thyroid tablets due to excessive potency.
Vitruvias Therapeutics, Inc. Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency - Business Wire
Vitruvias Therapeutics issued a nationwide recall of one lot of Thyroid Tablets, USP 30 mg because the medication may be overly potent.
Coverage above aggregates public news reporting using the GDELT news database and Google News, updated automatically without human review. It is general information, not legal advice, and does not indicate CaseValuation.com represents or is affiliated with any party, law firm, or plaintiff named above. CaseValuation.com is not a law firm. If you believe you're affected by one of these matters, consult a licensed attorney.